EmaxHealth Health News
Home » General Health » Drug Clinical Trials

Company Seeks To Increase Minority Representation In Clinical Drug Trials

Ads by Google

All About:
  • Drug Clinical Trials

By Armen Hareyan on November 9, 2007 - 12:46am for eMaxHealth

Ensuring that clinical research studies include a diverse population ofparticipants is "important because type 2 diabetes and a host of otherdiseases affect ethnic minority groups differently," the Indianapolis Star reports.

According to the Star, FDAhas been urging pharmaceutical companies to more closely examine howtheir drugs work in minority populations. An agency study showed thatfrom 1995 to 1999 minorities were seriously underrepresented in 2,581registered clinical trials for 185 drugs. Minorities often representfewer than 15% of patients in clinical drug trials.

Withoutinformation on how the drugs affect minorities, products can reach themarket based on flawed data, Nancy Jewell, president and CEO of the Indiana Minority Health Coalition,said. "It's a major issue in the minority community. If you don't havea minority partner in a clinical trial, there might be a possibilitythat a drug might not be as effective (for a) certain race or ethnicgroup," Jewell added.

Indianapolis-based company Anaclim, founded by two Eli Lillyexecutives in 2005, helps companies recruit minority participants fordrug trials, as well as minority physicians to run the tests.Currently, Anaclim is working on nine clinical trials that are studyingdiabetes and cardiovascular disease. It also has worked for smallbiotechnology companies, Rex Alexander, Anaclim's vice president ofclinical operations and co-founder, said.

Alfonso Alanis, CEOand co-founder of the company, said, "Minority investigators have beenignored in the clinical research business," adding, "They're going tobe major consumers of resources. It makes no sense to develop a drug ina population of patients that's not going to use the drug." Alexanderand Alanis plan to expand their company to areas outside the U.S., suchas Central America, Europe and India, in an effort to "open doors toeven more diverse populations," according to the Star (Bowen, Indianapolis Star, 11/6).
\t

Reprinted with permission from kaisernetwork \t\t\t\t\t\t\t

Reprinted with permission fromkaisernetwork.org.You can view the entire KaiserWeekly Health Disparities Report, search the archives,and sign up for email delivery at kaisernetwork.org/email. The Kaiser Weekly Health Disparities Report is published forkaisernetwork.org, a free service of The Henry J. Kaiser FamilyFoundation.

Source: 
kaisernetwork.org

eMaxHealth welcomes yourcomments and feedback on this story without registration, but keep the comments meaningful please. Links are not accepted.

  • Add new comment

Similar Stories

  • Medical Research in 2012 a Risk to the United States
  • Dexpramipexole promising in phase II trial for Lou Gehrig's disease
  • Lilly drug evacetrapib dramatically raises HDL cholesterol in trial
  • Genzyme’s MS Drug Lemtrada Gets Positive Results in Clinical Trial
  • Vorapaxar TRACER study halted after safety review

 Dr. Oz Promotes Magnet Cure
 Skin Care Secrets in Your Kitchen
 3 Gadgets to Make You Look 10 Years Younger
 Catalase is the Culprit for Gray Hair
 Vibration Therapy Helps Chronic Pain
 What If Antidepressants Don't Work
 When Obesity is OK for Some

Health Categories

 EMAXHEALTH HOME
 AFFORDABLE HEALTH INSURANCE
 DIET & WEIGHT LOSS
 FITNESS & EXERCISE
 MEN'S HEALTH
 WOMEN'S HEALTH
 BEAUTY
 ALTERNATIVE MEDICINE
 CANCER TREATMENT
 AGING
 DISEASE and CONDITION
 MENTAL HEALTH
 GENERAL HEALTH
 PERSONAL HEALTH
 GOURMET FOOD & HEALTH
 HEALING & SPIRITUALITY
 MONEY AND HEALTH
 Comment Moderation
  • Health RSS Feeds
  • Privacy Policy
  • Disclaimer
  • About Us
  • Editorial Review Process
  • Advertise
  • Contact
  • Contributors
Copyright eMaxhealth.com 2005-2012. All rights reserved.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.